Research findings to Therapeutic opportunity:
The study presented here suggests that MiRNA-9600, by decreasing the expression of its target genes, it may increase the expression of pro-apoptotic protein Fas Ligand (FasL).
[easy_payment currency=”USD”]
Thereby, it may inhibit proliferation, chemoresistance and apoptosis of cancer cells. Thus, pharmacological formulations encompassing “MiRNA-9600 activators” may be used to inhibit cancer progression.
Details of the research findings:
Idea Proposed/Formulated (with experimental evidence) by:
Dr L Boominathan Ph.D.
Undisclosed information: How MiRNA-9600 increases the expression of pro-apoptotic protein Fas ligand (FasL)
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Amount: $2
For purchase and payment details, you may reach us at info@genomediscovery.org
References:
Citation: Boominathan, L., Anticancer therapy: MiRNA-9600 increases the expression of pro-apoptotic protein Fas ligand (FasL) and inhibits proliferation, chemoresistance and apoptosis of cancer cells via down regulation of its target gene, 28/November/2016, 6.46 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org or newbioideas.com
Courtesy: When you cite drop us a line at info@genomediscovery.org